Serum sclerostin in vascular calcification in CKD: a meta-analysis
Vascular calcification (VC) is recognized as a predictor of all-cause and CVD mortality in chronic kidney disease (CKD). VC in CKD is possibly associated with serum sclerostin. The study systematically investigated the role of serum sclerostin in VC in CKD. Following the Preferred Reporting Items fo...
Saved in:
| Main Authors: | Yan Lin, Liman Mao, Siqi Chen, Canxin Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2023.2186151 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress of studies on sclerostin’s role in vascular calcification of chronic kidney disease
by: PENG Qiong-yao, et al.
Published: (2019-01-01) -
Association of serum sclerostin level with coronary artery calcification in maintenance hemodialysis patients
by: CHENG Jin, et al.
Published: (2019-01-01) -
The serum levels of FGF23, sclerostin, osteoprotegerin do not explain the inverse relationship between coronary calcifications and bone mineral density evaluated using computed tomography
by: Laurence Ferrières, et al.
Published: (2025-06-01) -
Association of total and bioactive serum sclerostin levels with bone metabolism in type 2 diabetes mellitus
by: Cyril Traechslin, et al.
Published: (2025-06-01) -
Role of sclerostin in mastocytosis bone disease
by: Aneta Szudy-Szczyrek, et al.
Published: (2025-01-01)